ALNYLAM PHARMACEUTICALS, INC. (ALNY) Operating income 2016–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual operating income history from SEC filings — each fiscal year as reported.
$501.6MFY2025 · since FY2016: -$424.6M → $501.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $501.6M | +383.6% |
| FY2024 | -$176.9M | +37.3% |
| FY2023 | -$282.2M | +64.1% |
| FY2022 | -$785.1M | -10.8% |
| FY2021 | -$708.7M | +14.5% |
| FY2020 | -$828.4M | +11.8% |
| FY2019 | -$939.4M | -15.3% |
| FY2018 | -$814.7M | -62.9% |
| FY2017 | -$500.1M | -17.8% |
| FY2016 | -$424.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice